An Online Survey for Women With Attention Deficit Hyperactivity Disorder (ADHD)

Last updated: July 15, 2025
Sponsor: Parnassia Groep
Overall Status: Completed

Phase

N/A

Condition

Attention Deficit/hyperactivity Disorder (Adhd - Adults)

Treatment

N/A

Clinical Study ID

NCT06169709
Survey Female ADHD
  • Ages > 18
  • Female

Study Summary

The goal of this exploratory study following a cross-sectional online survey in women with ADHD is to

  1. describe overall experiences regarding ADHD symptoms, diagnosis, treatment, sources of support, and any perceived barriers on those domains;

  2. determine which life domains are most affected by ADHD symptoms;

  3. calculate the prevalence of reported health conditions within the following domains: circulatory system, endocrine or metabolic system, gastrointestinal system, genitourinary system, musculoskeletal system, nervous system, respiratory system, skin, reproductive system, cancer, psychiatric conditions, COVID-19, sensory sensitivity, menstrual cycle, and sleep;

  4. identify topics that women with ADHD would like to see studied in future research.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Identify as a woman

  • Aged 18 or above

  • Have ADHD (both diagnosed by a health professional and self-diagnosed)

Exclusion

Exclusion Criteria:

  • People who are not able to read, understand, or sign the information letter orinformed consent form are excluded from participation.

Study Design

Total Participants: 5893
Study Start date:
February 20, 2024
Estimated Completion Date:
July 10, 2025

Study Description

Rationale: In clinical practice, the investigators see that ADHD affects women differently than men. It has become clear that a better understanding of ADHD in girls and women is needed to improve their longer-term wellbeing and functional and clinical outcomes.

Objective: The primary endpoint is to describe the overall experience of women with ADHD regarding ADHD symptoms, diagnosis, treatment, and any perceived barriers relating to these domains. The investigators also want to determine the effects of ADHD symptoms on day-to-day life across various life domains. Moreover, the investigators want to determine the prevalence of reported health conditions.

Study design: This is an exploratory study following a cross-sectional online survey.

Study population: Women (aged >18 years) with ADHD.

Intervention (if applicable): Not applicable.

Main study parameters/endpoints: In women with ADHD, the investigators want to 1) describe overall experiences regarding ADHD symptoms, diagnosis, treatment, sources of support, and any perceived barriers on those domains; 2) determine which life domains are most affected by ADHD symptoms; 3) calculate the prevalence of reported health conditions within the following domains: circulatory system, endocrine or metabolic system, gastrointestinal system, genitourinary system, musculoskeletal system, nervous system, respiratory system, skin, reproductive system, cancer, psychiatric conditions, COVID-19, sensory sensitivity, menstrual cycle, and sleep; 4) identify topics that women with ADHD would like to see studied in future research.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: This survey is the first to study experiences and health of women with ADHD internationally, and results will provide insights and leads for all involved with diagnosis and treatment of these women. Risks of participation are considered low. Participants might consider certain questions triggering, but are always free to skip questions and stop the survey.

Connect with a study center

  • Parnassia Groep

    Den Haag,
    Netherlands

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.